Candiduria in Renal Transplant Recipients
Ouanassa Hamouda* and Allaoua Hichem Fendri
Corresponding Author: Ouanassa Hamouda, Department of Medicine, University of Batna, Algeria.
Revised: October 06, 2021; Available Online: October 06, 2021
Citation: Hamouda O & Fendri AH. (2021) Candiduria in Renal Transplant Recipients. J Renal Transplant Sci, 3(S1): 03.
Copyrights: ©2021 Hamouda O & Fendri AH. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :
  • 2494

    Views & Citations
  • 1494

    Likes & Shares
Background: The incidence of candiduria has increased significantly in recent years. A prospective study was carried out from January 1, 2017 to June 31, 2017 in the nephrology department at the Batna University Hospital, the aim of which is to determine the incidence of candiduria.

Results: A total of 35 patients were included in our study, eight of them (22.85%) developed candiduria during their hospitalization. The majority of patients were women. The age group between 40-60 years was the most representative. Several risk factors were sought; the most frequently found were immunosuppressive treatment, corticosteroid therapy and broad- spectrum antibiotic therapy. Candida albicans was the most isolated species (62.5%). This study demonstrated the role of candiduria as a potential risk factor for systemic infection (candidemia); three cases of candidemia were diagnosed in patients with high candiduria. The death rate in our study was (37. 5%), they all had candidemia.

Conclusion: Candiduria can be associated with high morbidity and mortality. It is a major risk factor for systemic infections. Early post-transplantation screening is therefore essential.

Keywords: Candiduria, Renal transplant recipients, Candidemia, Candida albicans